Reddy Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.60 Cr
as on 08-07-2024
- Paid Up Capital ₹ 2.60 Cr
as on 08-07-2024
- Company Age 28 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.50 M
as on 08-07-2024
- Satisfied Charges ₹ 4.35 Cr
as on 08-07-2024
- Revenue -89.65%
(FY 2021)
- Profit -3310.30%
(FY 2021)
- Ebitda -633.56%
(FY 2021)
- Net Worth -19.13%
(FY 2021)
- Total Assets -23.96%
(FY 2021)
About Reddy Pharmaceuticals
The Corporate was formerly known as Reddy Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.60 Cr and a paid-up capital of Rs 2.60 Cr.
The company currently has active open charges totaling ₹0.50 M. The company has closed loans amounting to ₹4.35 Cr, as per Ministry of Corporate Affairs (MCA) records.
Surya Konda, Konda Reddy, and Vishnu Konda serve as directors at the Company.
- CIN/LLPIN
U24232TG1996PLC116710
- Company No.
116710
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
05 Jan 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Reddy Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Surya Konda | Director | Current | |
Konda Reddy  | Director | 05-Jan-1996 | Current |
| Vishnu Konda | Director | 10-Feb-2016 | Current |
Financial Performance of Reddy Pharmaceuticals.
Reddy Pharmaceuticals Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 89.65% decrease. The company also saw a substantial fall in profitability, with a 3310.3% decrease in profit. The company's net worth observed a substantial decline by a decrease of 19.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Reddy Pharmaceuticals?
In 2021, Reddy Pharmaceuticals had a promoter holding of 78.28% and a public holding of 21.72%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
P.N.B. Creation Date: 20 Sep 1989 | ₹0.50 M | Open |
Karnataka Bank Ltd. Creation Date: 24 Mar 2016 | ₹2.70 Cr | Satisfied |
Syndicate Bank Creation Date: 15 Oct 2004 | ₹1.65 Cr | Satisfied |
How Many Employees Work at Reddy Pharmaceuticals?
Reddy Pharmaceuticals has a workforce of 1 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reddy Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reddy Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
